Volume 6 Number 1 May 2010

EuroIntervention, a bright light

• Serruys PW

EuroIntervention 2010;6:1-00

The gap between vascular interventions and vascular medicine

• Ribichini F,
• Tomai F,
• Castriota F,
• Russo P,
• Reimers B

EuroIntervention 2010;6:25-27

The artery under the lens

• Prati F,
• Ramazzotti V

EuroIntervention 2010;6:15-17

The importance of preclinical research in contemporary interventional cardiology

• Joner M,
• Byrne R

EuroIntervention 2010;6:19-23

To whom does cardiac MSCT belong?

• Di Mario C,
• Pugliese F

EuroIntervention 2010;6:29-33

Consensus from the 5th European Bifurcation Club meeting

• Hildick-Smith D,
• Lassen J,
• Albiero R,
• Lefèvre T,
• Darremont O,
• Pan M,
• Ferenc M,
• Stankovic G,
• Louvard Y

EuroIntervention 2010;6:34-38

Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions: May 2010 update

• Cuisset T,
• Valgimigli M,
• Mudra H,
• Muller O,
• Wijns W,
• Huber K

EuroIntervention 2010;6:39-45

First human use of the TAXUS Petal paclitaxel-eluting bifurcation stent

• Ormiston J,
• Lefèvre T,
• Grube E,
• Allocco D,
• Dawkins K

EuroIntervention 2010;6:46-53

Mitral annular reduction with subablative therapeutic ultrasound: pre-clinical evaluation of the ReCor device

• Jilaihawi H,
• Virmani R,
• Nakagawa H,
• Ducharme A,
• Shi Y-F,
• Carter-Monroe N,
• Ladich E,
• Iyer M,
• Ikeda A,
• Asgar A,
• Bonan R

EuroIntervention 2010;6:54-62

Randomised comparison of titanium-nitride-oxide coated stents with bare metal stents: five year follow-up of the TiNOX trial

• Moschovitis A,
• Simon R,
• Seidenstücker A,
• Klauss V,
• Baylacher M,
• RN R,
• Lüscher T,
• Moccetti T,
• Windecker S,
• Meier B,
• Hess O

EuroIntervention 2010;6:63-68

Optical coherence tomography (OCT) strut-level analysis of drug-eluting stents (DES) in human coronary bifurcations

• Kyono H,
• Guagliumi G,
• Sirbu V,
• Rosenthal N,
• Tahara S,
• Musumeci G,
• Trivisonno A,
• Bezerra H,
• Costa M

EuroIntervention 2010;6:69-77

Optical coherence tomography for the assessment of pericardium covered stents for the treatment of degenerated saphenous vein grafts

• Tyczynski P,
• Kukreja N,
• van Geuns R-J,
• Wykrzykowska J,
• Sheppard M,
• Di Mario C

EuroIntervention 2010;6:78-85

Strut apposition after coronary stent implantation visualised with optical coherence tomography

• Radu M,
• Jørgensen E,
• Kelbaek H,
• Helqvist S,
• Skovgaard L,
• Saunamäki K

EuroIntervention 2010;6:86-93

Optical coherence tomography in unprotected left main coronary artery stenting

• Parodi G,
• Maehara A,
• Giuliani G,
• Kubo T,
• Mintz G,
• Migliorini A,
• Valenti R,
• Carrabba N,
• Antoniucci D

EuroIntervention 2010;6:94-99

Acute left main obstructions following TAVI

• Stabile E,
• Sorropago G,
• Cioppa A,
• Cota L,
• Agrusta M,
• Lucchetti V,
• Rubino P

EuroIntervention 2010;6:100-105

Incidence, predictors and prognostic importance of bleeding after primary PCI for ST-elevation myocardial infarction

• de Boer M,
• Hoorntje J,
• Gosselink A,
• Suryapranata H,
• van’t Hof A

EuroIntervention 2010;6:106-111

A randomised comparison between everolimus-eluting stent and sirolimus-eluting stent in chronic coronary total occlusions. Rationale and design of the CIBELES (non-acute Coronary occlusion treated By EveroLimus-Eluting Stent) trial

• Moreno R,
• Garcia E,
• Teles R,
• Almeida M,
• Carvalho H,
• Sabate M,
• Martin-Reyes R,
• Rumoroso J,
• Galeote G,
• Goicolea F,
• Moreu J,
• Mainar V,
• Mauri J,
• Ferreira R,
• Valdes M,
• de Prado A,
• Martin-Yuste V,
• Jimenez-Valero S,
• Sánchez-Recalde A,
• Calvo L,
• de Sa E,
• Macaya C,
• López-Sendón J-L

EuroIntervention 2010;6:112-116

Endothelial function rather than endothelial restoration is altered in paclitaxel- as compared to bare metal-, sirolimus and tacrolimus-eluting stents

• van Beusekom H,
• Sorop O,
• van den Heuvel M,
• Onuma Y,
• Duncker D,
• Danser A,
• van der Giessen WJ

EuroIntervention 2010;6:117-125

Polymer-free cerivastatin-eluting stent shows superior neointimal inhibition with preserved vasomotor function compared to polymer-based paclitaxel-eluting stent in rabbit iliac arteries

• Pendyala L,
• Yin X,
• Li J,
• Shinke T,
• Xu Y,
• Chen J,
• King III S,
• Colley K,
• Goodchild T,
• Chronos N,
• Hou D

EuroIntervention 2010;6:126-133

A perlecan-inducing compound significantly inhibits smooth muscle cell function and in-stent intimal hyperplasia: novel insights into the diverse biological effects of perlecan

• Segev A,
• Nili N,
• Osherov A,
• Qiang B,
• Wong A,
• Pillarisetti S,
• Strauss B

EuroIntervention 2010;6:134-140

Micro-computed tomographic assessment following extremely oversized partial postdilatation of drug-eluting stents

• Basalus M,
• van Houwelingen K,
• Ankone M,
• Feijen J,
• von Birgelen C

EuroIntervention 2010;6:141-148

Safety and efficacy of drug-eluting stents versus bare-metal stents in saphenous vein grafts lesions: a meta-analysis

• Sánchez-Recalde A,
• Valero S,
• Moreno R,
• Barreales L,
• Lozano I,
• Galeote G,
• Reyes R,
• Calvo L,
• López-Sendón J-L

EuroIntervention 2010;6:149-160

How should I treat a tortuous calcified right coronary artery?

• Garg S,
• Schultz C,
• Sarno G,
• Serruys PW

EuroIntervention 2010;6:161-167

Coronary guidewires

• Erglis A

EuroIntervention 2010;6:168-169

Induction of mechanical and ST-T alternans following angioplasty in severe heart failure

• Jokhi P,
• O’ Kane P

EuroIntervention 2010;6:171